Aileron Therapeutics, Inc. Common Stock ($0.001 par value per share) Capital on Demand™ Sales AgreementAileron Therapeutics Inc • January 29th, 2021 • Pharmaceutical preparations • New York
Aileron Therapeutics, Inc., a Delaware corporation (the “Company”) confirms its agreement (this “Agreement”) with JonesTrading Institutional Services LLC (“JonesTrading”) and William Blair & Company, L.L.C. (“William Blair”; each of JonesTrading and William Blair individually an “Agent” and collectively, the “Agents”) as follows:
